Review Article

National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency


Primary immunodeficiency (PID) is a group of more than 400 distinct genetic disorders affecting both children and adults. As signs and symptoms of PID are usually heterogeneous and unspecific, diagnosis and follow-up of these patients can be challenging based on the available human resources and laboratory facilities. In order to reach a distinct national protocol and due to little evidence to guide appropriate or universal guidelines to improve the current status of management of the disease, the Iranian PID network designed a consensus appropriate for regional resources. This review summarizes this PID guideline based on the importance of different clinical complications and the level of medical authority visiting those at the first line. Moreover, for each complication, appropriate interventions for improving approach are mentioned.
1. Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. Journal of clinical immunology. 2018 Jan;38(1):96-128. PubMed PMID: 29226302. Pubmed Central PMCID: 5742601.
2. Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in iran. Iranian journal of pediatrics. 2010 Mar;20(1):16-34. PubMed PMID: 23056678. Pubmed Central PMCID: 3446008.
3. Abolhassani H, Rezaei N, Aghamohammadi A. Recent Advances and Current Status of Primary Immunodeficiency Disease in Iran. Immunology and Genetics Journal. 2018;1(1):1-33.
4. Richardson AM, Moyer AM, Hasadsri L, Abraham RS. Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases). Current allergy and asthma reports. 2018 Feb 22;18(3):19. PubMed PMID: 29470720.
5. Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, et al. Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS immunology and medical microbiology. 2004 Mar 8;40(2):113- 8. PubMed PMID: 14987729.
6. Rezaei N, Abolhassani H, Aghamohammadi A, Ochs HD. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Expert review of clinical immunology. 2011 May;7(3):301-16. PubMed PMID: 21595597.
7. Mozaffari H, Pourpak Z, Pourseyed S, Moin M, Farhoodi A, Aghamohammadi A, et al.Health-related quality of life in primary immune deficient patients. Iranian journal of allergy, asthma, and immunology. 2006 Mar;5(1):23-7. PubMed PMID: 17242500.
8. Aghamohammadi A, Pouladi N, Parvaneh N, Yeganeh M, Movahedi M, Gharagolou M, et al. Mortality and morbidity in common variable immunodeficiency. Journal of tropical pediatrics. 2007 Feb;53(1):32-8. PubMed PMID: 17166933.
9. Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, et al. Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency. Iranian journal of allergy, asthma, and immunology. 2003 Sep;2(3):121-6. PubMed PMID: 17301367.
10. Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, Movahedi M, Parvaneh N, Pouladi N, et al. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. Journal of investigational allergology & clinical immunology. 2009;19(2):139-45. PubMed PMID: 19476018.
11. Aghamohammadi A, Farhoudi A, Nikzad M, Moin M, Pourpak Z, Rezaei N, et al. Adverse reactions of prophylactic intravenous immunoglobulin infusions in Iranian patients with primary immunodeficiency. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2004 Jan;92(1):60-4. PubMed PMID: 14756466.
12. Abolhassani H, Sadaghiani MS, Aghamohammadi A, Ochs HD, Rezaei N. Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. Journal of clinical immunology. 2012 Dec;32(6):1180-92. PubMed PMID: 22730009.
13. Ghavamzadeh A, Alimoghaddam K, Ghaffari F, Derakhshandeh R, Jalali A, Jahani M. Twenty years of experience on stem cell transplantation in iran. Iranian Red Crescent medical journal. 2013 Feb;15(2):93-100. PubMed PMID: 23682320. Pubmed Central PMCID: 3652510.
14. Hamidieh A, Pourpak Z, Jalili M, Fazlollahi M, Behfar M, Movahedi M, et al. Haematopoietic stem cell transplantation in primary immunodeficiency diseases: the Iranian experience. 2012.
15. Nourijelyani K, Aghamohammadi A, Salehi Sadaghiani M, Behniafard N, Abolhassani H, Pourjabar S, et al. Physicians awareness on primary immunodeficiency disorders in Iran. Iranian journal of allergy, asthma, and immunology. 2012 Mar;11(1):57- 64. PubMed PMID: 22427477.
16. Isaian A, Moin M, Pourpak Z, Rezaei N, Aghamohammadi A, Movahedi M, et al. DNA banking of primary immunodeficiency disorders in iran. Iranian journal of allergy, asthma, and immunology. 2006 Dec;5(4):201- 2. PubMed PMID: 17237575.
IssueVol 2, No 1 (2019) QRcode
SectionReview Article
Primary immunodeficiency Symptoms Management consensus guideline

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Abolhassani H, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Movahedi M, Hamidieh AA, Behniafard N, Nabavi M, Arshi S, Bemanian MH, Fallahpour M, Shokri S, Molatefi R, Sherkat R, Shirkani A, Amin R, Aleyasin S, Faridhosseini R, Jabbari-Azad F, Mohammadzadeh I, Ghaffari J, Shafiei A, Kalantari A, Mansouri M, Mesdaghi M, Babaie D, Ahanchian H, Khoshkhui M, Soheili H, Eslamian MH, Cheraghi T, Dabbaghzadeh A, Tavassoli M, Nasiri Kalmarzi R, Mortazavi SH, Kashef S, Esmaeilzadeh H, Tafaroji J, Khalili A, Zandieh F, Sadeghi-Shabestari M, Darougar S, Behmanesh F, Akbari H, Zandkarimi M, Abolnezhadian F, Fayezi A, Moghtaderi M, Ahmadiafshar A, Shakerian B, Sajedi V, Taghvaei B, Safari M, Heidarzadeh M, Ghalehbaghi B, Fathi SM, Darabi B, Bazregari S, Bazargan N, Khayatzadeh A, Javahertrash N, Bashardoust B, Zamani M, Mohsenzadeh A, Ebrahimi S, Sharafian S, Vosughimotlagh A, Tafakoridelbari M, Rahimi M, Ashournia P, Razaghian A, Aghaeimeybodi F, Mamishi S, Parvaneh N, Rezaei N, Aghamohammadi A. National Consensus on Diagnosis and Management Guidelines for Primary Immunodeficiency. Immunol Genet J. 2019;2(1):1-21.